from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3836/-

LFCtreatmentdescriptionclass of inhibitor

-2.101

Amikacinug/mL Amikacintranslation

-1.013

Cap5-10ug/mL Capreomycintranslation

-0.997

Rox10-50 ug/mL Roxithromycintranslation

-0.069

SM2-5 ug/mL Streptomycintranslation

-3.257

Tet5-10 ug/mL Tetracyclinetranslation

-1.122

Rif0.2-5ug/mL Rifampicintranscription

0.198

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.589

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.874

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

1.551

Clofazimine10-13 ug/mL Clofaziminerespiration

0.855

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.217

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.053

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.128

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.878

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.742

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.261

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.718

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.518

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.352

KCN5-20 ug/mL Potassium cyaniderespiration

-0.063

NaN30.2-2 mM Sodium aziderespiration

1.290

Nigericin50 uM Nigericinrespiration

-0.738

TRC10-150 ug/mL Triclosanrespiration

-0.617

TRZ10-25 ug/mL Thioridazinerespiration

-0.009

Valinomycin0.5-10 uM Valinomycinrespiration

0.844

ZnSO42 mM ZnSO4respiration

0.462

menadione6-10 ug/mL Menadionerespiration

0.338

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.546

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.253

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.955

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.362

NRP_1Non-replicating persistence stage 1dosRassociated

0.572

Amp0.2mg/mL AmpicillincellWall

0.157

Cephalexin20-100 ug/mL CephalexincellWall

0.984

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.805

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.279

EMB10-20 ug/mL EthambutolcellWall

-0.192

Eta12-40 ug/mL EthionamidecellWall

-0.643

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.211

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.218

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.479

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.366

BZA0.12 mg/mL BenzamidearomaticAmides

-0.537

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.167

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.217

H2O24 mM hydrogen peroxideDNAdamaging

-0.070

Levo10 ug/mL LevofloxacinDNAdamaging

0.087

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.758

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.234

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.081

UVUV-irradiationDNAdamaging

-0.638

ARP41-4 ug/mL Antitubercular compound ARP4?

0.067

Antimycin12.5-50 ug/mL Antimycin A?

1.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.119

PA_110-50 ug/mL Antitubercular compound PA-1?

0.291

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.554

PA8240.2-2 ug/mL PA-824?

0.726

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.101

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.125

Verapamil50 uM Verapamil?

0.722

mercaptoethanol2 mM 2-Mercaptoethanol?

1.728

methoxatin10-20 ug/mL Methoxatin?